Journal of Medicinal Chemistry · 2010 · 53 citations · 14 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyChemical Library DesignLigand BindingLigand-based DesignMolecular DockingProtein-ligand DockingStructure-activity Relationship AnalysisBcl-2 Protein StructureDocking-based Drug DesignMacrocyclic InhibitorsMcl-1 FunctionMolecular Docking Of InhibitorsMutant LibrariesSmall-molecule DockingSmall-molecule Library Design
The screening of a small focused library of rhodanine derivatives as inhibitors of Bcl-2 proteins led to the discovery of two structurally related compounds with different binding profiles against the Bcl-XL and the Mcl-1 proteins. Subsequent NMR studies with mutant proteins and in silico docking studies provide a possible rationale for the observed specificity.
14
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Tilman Oltersdorf, Steven W. Elmore, Alexander R. Shoemaker et al. · Nature · 2005 · 3.4K citations
Python: a programming language for software integration and development.
M F Sanner · PubMed · 1999 · 3.1K citations
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Christin Tse, Alexander R. Shoemaker, Jessica Adickes et al. · Cancer Research · 2008 · 2K citations · Full text
Medicine, Oncology, Pharmacology +16